Ticker Symbol: SNDX
Syndax Pharmaceuticals Inc
$18.30 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001395937
Company Profile
Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the Menin-MLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Building D
Website: www.syndax.com
CEO: Briggs Morrison
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $11.99
Change:
-$0.26
(
-2.12%)
Days Range: $11.92 - $12.42
Beta: 0.83
52wk. High: $29.86
52wk. Low: $11.34
Ytd. Change -55.01%
50 Day Moving Average: $14.84
200 Day Moving Average: $19.04
Shares Outstanding: 69484053
Valuation
Market Cap: 83.3B
PE Ratio: -51.42
EPS (TTM): -0.2332
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A